AMAG Pharmaceuticals Inc. said Wednesday that it has named Greg Madison as executive vice president and chief commercial officer. Madison joins the Lexington company from Genzyme Corp., where he spent 12 years in various commercial roles in the renal division, most recently as vice president and general manager. AMAG chief executive William K. Heiden said Madison’s experience will play a key role in the evaluation and the commercialization of future assets.
AMAG names top commercial officer
You have reached the limit of 10 free articles in a month
Stay informed with unlimited access to Boston’s trusted news source.
- High-quality journalism from the region’s largest newsroom
- Convenient access across all of your devices
- Today’s Headlines daily newsletter
- Subscriber-only access to exclusive offers, events, contests, eBooks, and more
- Less than 25¢ a week